2014 Press Releases

Keyword Search
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010
DateTitle 
12/22/14CORRECTION - West Announces Quarterly Dividend
EXTON, PA -- (Marketwired) -- 12/22/14 -- In the news release issued Friday, December 19, 2014 by West Pharmaceutical Services, Inc. (NYSE: WST), we are advised by the company that the originally issued headline was incorrect. Complete corrected text follows. West Announces Quarterly Dividend EXTON, PA - December 19, 2014 - West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2015 dividend of $0.11 per share. The di... 
Printer Friendly Version
12/19/14West Announces 10% Increase in Quarterly Dividend
EXTON, PA -- (Marketwired) -- 12/19/14 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2015 dividend of $0.11 per share. The dividend will be paid on February 4, 2015 to shareholders of record as of January 21, 2015. About West West is by the side of its healthcare partners from concept to the patient, designing and manufacturing packaging, diagnostic and delivery systems that promote the efficiency, reliab... 
Printer Friendly Version
12/01/14West Provides Required Notice of Automatic Conversion of Debentures
EXTON, PA -- (Marketwired) -- 12/01/14 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced the automatic conversion of the 4% convertible junior subordinated debentures due March 15, 2047 ("Debentures") that remain outstanding on December 9, 2014 ("Conversion Date"). On the Conversion Date, the Company will: Issue 36.5008 shares of its common stock for each $1,000 principal amount of Debentures, paying cash in lieu of fractional shares to each holder; and ... 
Printer Friendly Version
11/11/14West Receives 510(k) Clearance for NovaGuard™ SA Safety System
Staked-needle prefillable syringe safety system helps reduce risk of needlestick injury to healthcare workers and patients EXTON, Pa., Nov. 11, 2014 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the NovaGuard SA (Staked-needle Automatic) safety system has received 510(k) clearance from the United States Food and Drug Administration. The NovaGuard SA safety system helps reduce t... 
Printer Friendly Version
10/30/14West Announces Third Quarter 2014 Results
Conference Call Scheduled for 9 a.m. Today EXTON, PA -- (Marketwired) -- 10/30/14 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter of 2014 and updated its revenue and gross margin guidance for 2014 and its long-term financial objectives. In addition, the Company announced a $100 million share repurchase program. Highlights Third quarter sales grew 4.1% on proprietary delivery systems growth Adjusted... 
Printer Friendly Version
10/23/14West to Host Third Quarter 2014 Conference Call
EXTON, PA -- (Marketwired) -- 10/23/14 -- West Pharmaceutical Services, Inc. (NYSE: WST) today that it will release third quarter 2014 financial results before the market opens on Thursday, October 30, 2014 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 877-280-4960 (U.S.) or 857-244-7317 (International). The passcode is 46283848. A live broadcast of the conference call will be available... 
Printer Friendly Version
10/21/14West's Vial2Bag DC Device Receives U.S. FDA 510(k) Clearance and CE Mark
Universal needle-free reconstitution and transfer system now available for use in hospitals EXTON, Pa., Oct. 21, 2014 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, has received 510(k) clearance of the Vial2Bag® DC device from the United States Food and Drug Administration, and also the CE Mark for the European Union. The Vial2Bag DC device is produced by West's subsidiary, Medimop Medical Pro... 
Printer Friendly Version
10/15/14West Pharmaceutical Services Announces CEO Retirement and Succession Plan
Chairman and CEO Donald E. Morel, Jr. to Retire at 2015 Annual Meeting Company Commences Search for Successor; Updates 2014 Outlook EXTON, Pa., Oct. 15, 2014 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative drug packaging and administration systems, said today that Donald E. Morel, Jr., Ph.D., Chairman of the Board and Chief Executive Officer, has announced his intention to retire at the Company's Annual Meeting in May 2015.  The West Board of... 
Printer Friendly Version
10/07/14West Names New President of Pharmaceutical Packaging Systems
EXTON, Pa., Oct. 7, 2014 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) has appointed Karen Flynn President of the company's Pharmaceutical Packaging Systems business. Pharmaceutical Packaging Systems is a global business unit within West, and is the company's largest, generating annual sales revenue of nearly $1 billion. "Karen has a strong track record of growing revenue, while maintaining high team engagement and motivation, and has been incredibly successful in the manag... 
Printer Friendly Version
10/06/14West Pharmaceutical Services and HealthPrize Technologies Join Forces on Connected Health
Collaboration designed to improve and reward medication adherence EXTON, Pa., Oct. 6, 2014 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) and HealthPrize Technologies, LLC today announced a strategic collaboration to integrate HealthPrize's Software-as-a-Service (SaaS) medication adherence and patient engagement platform with West's injectable drug delivery systems, to provide an end-to-end connected health solution to pharmaceutical companies and the patients they serve. Th... 
Printer Friendly Version
10/02/14West Announces Plans for a New Pharmaceutical Component Manufacturing Plant in Ireland
Expands global capabilities to meet customer demand WATERFORD, Ireland, Oct. 2, 2014 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today it plans to expand its global manufacturing operations to include a new site in Waterford, Ireland. The new facility will produce packaging components for insulin injector cartridges and other high-value packaging components, in order to meet growing d... 
Printer Friendly Version
09/02/14West to Present at Upcoming Investor Conferences
EXTON, PA -- (Marketwired) -- 09/02/14 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will participate in two upcoming investor conferences. Management will be presenting an overview of West's business and outlook at each of the following conferences: CL King's 12th Annual Best Ideas Conference, New York, NY Tuesday, September 9, 2014 at 2:00 PM Eastern Time Morgan Stanley Global Healthcare Conference 2014, New York, NY Wednesday, Sept... 
Printer Friendly Version
07/31/14West Announces Second Quarter 2014 Results
Conference Call Scheduled for 9 a.m. Today EXTON, PA -- (Marketwired) -- 07/31/14 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second quarter of 2014 and updated its revenue and gross margin guidance for the year. Highlights Second quarter sales grew 7.1% (5.3% excluding currency effects) Diluted EPS was $0.52 vs. $0.43 in the prior-year quarter Results driven by sales growth of higher-margin pro... 
Printer Friendly Version
07/24/14West To Host Second Quarter 2014 Conference Call
EXTON, Pa., July 24, 2014 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE:WST) announced today that it will release second quarter 2014 financial results before the market opens on Thursday, July 31, 2014 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 800-706-7749 (U.S.) or 617-614-3474 (International). The passcode is 66229803. A live broadcast of the conference call will be ... 
Printer Friendly Version
07/16/14CORRECTION -- West Announces 10% Increase in Quarterly Dividend
EXTON, PA -- (Marketwired) -- 07/16/14 -- In the news release, "West Announces 10% Increase in Quarterly Dividend," issued earlier today by West Pharmaceutical Services Inc. (NYSE: WST), we are advised by the company that the last sentence of the first paragraph should read "The fourth-quarter dividend will be paid on November 5, 2014 to shareholders of record as of October 22, 2014." rather than "The fourth-quarter dividend will be paid on November 3, 2014 to shareholders of record as of Octo... 
Printer Friendly Version
07/16/14West Announces 10% Increase in Quarterly Dividend
EXTON, PA -- (Marketwired) -- 07/16/14 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a fourth-quarter 2014 dividend of $0.11 per share, a 10% increase over the $0.10 per share declared for each of the four preceding quarters. This is the twenty-second consecutive annual increase in the Company's dividend. The fourth-quarter dividend will be paid on November 3, 2014 to shareholders of record as of October 19, 2014. About W... 
Printer Friendly Version
07/16/14West Dedicates Pharmaceutical Manufacturing Plant in India
Expands Presence in Asia Markets CHENNAI, India, July 16, 2014 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) has dedicated its manufacturing plant in the Sri City Special Economic Zone (SEZ), where the company will expand its growing primary packaging for injectable medicines business. "West is experiencing a very exciting period of growth and business expansion in Asia and we are proud to open our first facility in India," said Donald E. Morel, Jr., West's Chairman an... 
Printer Friendly Version
05/14/14West to Host Analyst and Investor Day
EXTON, PA -- (Marketwired) -- 05/14/14 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the company will host an Analyst and Investor Day for financial analysts on Thursday, May 22, 2014 from 8:30 am to 11:30 am EDT in New York, NY. Members of West's senior management will provide an overview of the company's current markets, operations, and growth opportunities. Presentations will begin at 9:00 am EDT. For additional information and registration, please e-mail west@west... 
Printer Friendly Version
05/08/14West Announces Third Quarter 2014 Dividend
EXTON, PA -- (Marketwired) -- 05/08/14 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board of Directors approved payment of the third-quarter 2014 cash dividend of $0.10 per share. The dividend will be paid on August 6, 2014 to shareholders of record on July 23, 2014. About West West works side-by-side with its healthcare partners from concept to the patient, designing and manufacturing packaging, diagnostic and delivery systems that promote the efficiency, reli... 
Printer Friendly Version
05/06/14West to Present at Upcoming Investor Conferences
EXTON, PA -- (Marketwired) -- 05/06/14 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will participate in three upcoming investor conferences. Management will be presenting an overview of West's business and outlook at each of the following conferences: Bank of America Merrill Lynch 2014 Healthcare Conference, Las Vegas, NV Tuesday, May 13, 2014 at 5:00 PM Pacific Time UBS Global Healthcare Conference, New York, NY Monday, May 19, 2014... 
Printer Friendly Version
05/01/14West Announces First Quarter 2014 Results
Conference Call Scheduled for 9 a.m. Today EXTON, PA -- (Marketwired) -- 05/01/14 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first quarter of 2014 and updated its financial guidance for the year. Highlights First quarter sales grew 1.2% excluding currency effects Diluted EPS was $0.38 vs. prior-year adjusted comparable of $0.44 Affirms prior guidance and narrows 2014 diluted EPS guidance to bet... 
Printer Friendly Version
04/24/14West to Host First Quarter 2014 Conference Call
EXTON, PA -- (Marketwired) -- 04/24/14 -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release first quarter 2014 financial results before the market opens on Thursday, May 1, 2014 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 866-383-8009 (U.S.) or 617-597-5342 (International). The passcode is 97017517. A live broadcast of the conference call will be avai... 
Printer Friendly Version
03/06/14West to Present at Barclays Conference
EXTON, PA -- (Marketwired) -- 03/06/14 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will attend the 2014 Barclays Global Healthcare Conference Healthcare Conference in Miami, FL. Management will present an overview of West's business and outlook on Thursday, March 13, 2013 at 9:00 AM Eastern Time. A live audio webcast of the Company's presentation, as well as a copy of the presentation materials, will be accessible from the Company's website at www.westphar... 
Printer Friendly Version
02/20/14West Appoints Director and Announces Second Quarter 2014 Dividend
EXTON, PA -- (Marketwired) -- 02/20/14 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board of Directors increased the size of the Board to eleven and appointed Myla Lai-Goldman, M.D., for a term that will expire at the 2014 Annual Meeting of Shareholders, when she will stand for election. Dr. Lai-Goldman, 56, is Chief Executive Officer and President of GeneCentric Diagnostics, Inc., a Durham, NC based molecular diagnostics company of which she is also a founder an... 
Printer Friendly Version
02/20/14West Announces Fourth Quarter 2013 Results
Conference Call Scheduled for 9 a.m. Today EXTON, PA -- (Marketwired) -- 02/20/14 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth quarter and full year 2013 and provided annual financial guidance for 2014. Highlights Fourth-quarter sales grew 5.1% excluding currency effects Fourth-quarter adjusted diluted EPS rose 26.7% to $0.38 per share Reported EPS of $0.33 includes discret... 
Printer Friendly Version
02/13/14West to Host Fourth Quarter and Full Year 2013 Conference Call
EXTON, PA -- (Marketwired) -- 02/13/14 -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release fourth quarter and full year 2013 financial results before the market opens on Thursday, February 20, 2014 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 800-510-9691 (U.S.) or 617-614-3453 (International). The passcode is 13353040. A live broadcast of the confere... 
Printer Friendly Version
West Pharma Callout
Contact Investor Relations